Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis-Reference-Cited by-同舟云学术

Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis

Published:2009-03 Issue:6 Volume:103 Page:806-811
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Giusti Betti,Gori Anna Maria,Marcucci Rossella,Saracini Claudia,Sestini Ilaria,Paniccia Rita,Buonamici Piergiovanni,Antoniucci David,Abbate Rosanna,Gensini Gian Franco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events;Eikelboom;Circulation,2002

2. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

3. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary interventions despite clopidogrel pre-treatment;Chen;J Am Coll Cardiol,2004

4. Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention;Chen;Am J Cardiol,2005

5. Stent thrombosis is associated with an impaired response to antiplatelet therapy;Wenaweser;J Am Coll Cardiol,2005

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach;International Journal of Cardiology;2024-11

2. Acute Coronary Syndrome;Primary Care: Clinics in Office Practice;2024-03

3. Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy;Journal of Personalized Medicine;2023-09-12

4. Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial;Frontiers in Pharmacology;2023-01-18

5. CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD);American Heart Journal;2022-12